Style | Citing Format |
---|---|
MLA | Ghaffarinazari H, et al.. "Radiation Dose and Schedule Influence the Abscopal Effect in a Bilateral Murine Ct26 Tumor Model." International Immunopharmacology, vol. 108, no. , 2022, pp. -. |
APA | Ghaffarinazari H, Alimohammadi M, Alimohammadi R, Rostami E, Bakhshandeh M, Webster TJ, Mahmoodi Chalbatani G, Tavakkolafshari J, Amir Jalali S (2022). Radiation Dose and Schedule Influence the Abscopal Effect in a Bilateral Murine Ct26 Tumor Model. International Immunopharmacology, 108(), -. |
Chicago | Ghaffarinazari H, Alimohammadi M, Alimohammadi R, Rostami E, Bakhshandeh M, Webster TJ, Mahmoodi Chalbatani G, Tavakkolafshari J, Amir Jalali S. "Radiation Dose and Schedule Influence the Abscopal Effect in a Bilateral Murine Ct26 Tumor Model." International Immunopharmacology 108, no. (2022): -. |
Harvard | Ghaffarinazari H et al. (2022) 'Radiation Dose and Schedule Influence the Abscopal Effect in a Bilateral Murine Ct26 Tumor Model', International Immunopharmacology, 108(), pp. -. |
Vancouver | Ghaffarinazari H, Alimohammadi M, Alimohammadi R, Rostami E, Bakhshandeh M, Webster TJ, et al.. Radiation Dose and Schedule Influence the Abscopal Effect in a Bilateral Murine Ct26 Tumor Model. International Immunopharmacology. 2022;108():-. |
BibTex | @article{ author = {Ghaffarinazari H and Alimohammadi M and Alimohammadi R and Rostami E and Bakhshandeh M and Webster TJ and Mahmoodi Chalbatani G and Tavakkolafshari J and Amir Jalali S}, title = {Radiation Dose and Schedule Influence the Abscopal Effect in a Bilateral Murine Ct26 Tumor Model}, journal = {International Immunopharmacology}, volume = {108}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Ghaffarinazari H AU - Alimohammadi M AU - Alimohammadi R AU - Rostami E AU - Bakhshandeh M AU - Webster TJ AU - Mahmoodi Chalbatani G AU - Tavakkolafshari J AU - Amir Jalali S TI - Radiation Dose and Schedule Influence the Abscopal Effect in a Bilateral Murine Ct26 Tumor Model JO - International Immunopharmacology VL - 108 IS - SP - EP - PY - 2022 ER - |